» Articles » PMID: 33134492

Rejection-associated Mitochondrial Impairment After Heart Transplantation

Overview
Publisher Wolters Kluwer
Specialty General Surgery
Date 2020 Nov 2
PMID 33134492
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mitochondrial dysfunction is associated with poor allograft prognosis. Mitochondrial-related gene expression (GE) in endomyocardial biopsies (EMBs) could be useful as a nonimmune functional marker of rejection. We hypothesize that acute cardiac allograft rejection is associated with decreased mitochondrial-related GE in EMBs.

Methods: We collected 64 routines or clinically indicated EMB from 47 patients after heart transplant. The EMBs were subjected to mRNA sequencing. We conducted weighted gene coexpression network analysis to construct module-derived eigengenes. The modules were assessed by gene ontology enrichment and hub gene analysis. Modules were correlated with the EMBs following the International Society of Heart and Lung Transplantation histology-based criteria and a classification based on GE alone; we also correlated with clinical parameters.

Results: The modules enriched with mitochondria-related and immune-response genes showed the strongest correlation to the clinical traits. Compared with the no-rejection samples, rejection samples had a decreased activity of mitochondrial-related genes and an increased activity of immune-response genes. Biologic processes and hub genes in the mitochondria-related modules were primarily involved with energy generation, substrate metabolism, and regulation of oxidative stress. Compared with International Society of Heart and Lung Transplantation criteria, GE-based classification had stronger correlation to the weighted gene coexpression network analysis-derived functional modules. The brain natriuretic peptide level, ImmuKnow, and Allomap scores had negative relationships with the expression of mitochondria-related modules and positive relationships with immune-response modules.

Conclusions: During acute cardiac allograft rejection, there was a decreased activity of mitochondrial-related genes, related to an increased activity of immune-response genes, and depressed allograft function manifested by brain natriuretic peptide elevation. This suggests a rejection-associated mitochondrial impairment.

Citing Articles

Out of the ice age: Preservation of cardiac allografts with a reusable 10 °C cooler.

Trahanas J, Harris T, Petrovic M, Dreher A, Pasrija C, DeVries S JTCVS Open. 2024; 21:197-209.

PMID: 39534335 PMC: 11551297. DOI: 10.1016/j.xjon.2024.08.005.


Unsupervised mRNA-seq classification of heart transplant endomyocardial biopsies.

Romero E, Tabak E, Fishbein G, Litovsky S, Tallaj J, Liem D Clin Transplant. 2023; 37(9):e15011.

PMID: 37151104 PMC: 10524567. DOI: 10.1111/ctr.15011.


Microvesicular Steatosis and Severe Cardiac Allograft Dysfunction.

Mai X, Alvarez P, Rodriguez E, Tan C, Boyle G Transplant Direct. 2022; 8(3):e1290.

PMID: 35187215 PMC: 8843365. DOI: 10.1097/TXD.0000000000001290.


Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection.

Scheiber D, Zweck E, Albermann S, Jelenik T, Spieker M, Bonner F ESC Heart Fail. 2021; 8(6):4674-4684.

PMID: 34490749 PMC: 8712779. DOI: 10.1002/ehf2.13607.


Mitochondrial Consequences of Organ Preservation Techniques during Liver Transplantation.

Horvath T, Jasz D, Barath B, Poles M, Boros M, Hartmann P Int J Mol Sci. 2021; 22(6).

PMID: 33802177 PMC: 7998211. DOI: 10.3390/ijms22062816.


References
1.
Bertero E, Maack C . Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018; 15(8):457-470. DOI: 10.1038/s41569-018-0044-6. View

2.
Kalisky T, Oriel S, Bar-Lev T, Ben-Haim N, Trink A, Wineberg Y . A brief review of single-cell transcriptomic technologies. Brief Funct Genomics. 2017; 17(1):64-76. DOI: 10.1093/bfgp/elx019. View

3.
Lu W, Zheng J, Pan X, Sun L . Diagnostic performance of echocardiography for the detection of acute cardiac allograft rejection: a systematic review and meta-analysis. PLoS One. 2015; 10(3):e0121228. PMC: 4378940. DOI: 10.1371/journal.pone.0121228. View

4.
Gvozdjakova A, Kucharska J, Mizera S, Braunova Z, Schreinerova Z, Schramekova E . Coenzyme Q10 depletion and mitochondrial energy disturbances in rejection development in patients after heart transplantation. Biofactors. 1999; 9(2-4):301-6. DOI: 10.1002/biof.5520090227. View

5.
Kucharska J, Gvozdjakova A, Mizera S, Braunova Z, Schreinerova Z, Schramekova E . Participation of coenzyme Q10 in the rejection development of the transplanted heart: a clinical study. Physiol Res. 1999; 47(6):399-404. View